Guangzhou Innogen Pharmaceutl Grp Co Ltd (02591.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 3.87

From 52W high−91.52%

Volume5.30M

Market capHKD 1.70B

P/E (TTM)—

P/S (TTM)9.6x

Div yield—

Key dataSep 18, 2026

Open

HKD 3.87

From 52W high

−91.52%

Volume

5.30M

Market cap

HKD 1.70B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.8x

P/E (TTM)

—

RSI (14)

34.8

MomentumView details →

1D Return

+0.26%

YTD Return

−87.43%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.8x

EV/Sales

3.9x

P/S (TTM)

9.6x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

76.01%

Net Margin

−218.03%

EBITDA Margin

−211.04%

ROE (TTM)

−34.95%

ROA (TTM)

−25.32%

Asset Turnover

0.11x

GrowthView details →

Revenue YoY

+172.92%

EPS YoY

−45.10%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−100.00%

EBITDA YoY

−52.17%

MomentumView details →

1D Return

+0.26%

YTD Return

−87.43%

1Y Return

−90.86%

RSI (14)

34.8

vs 50D SMA

−33.22%

vs 200D SMA

−78.62%

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

3.50x

Quick Ratio

3.15x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.29

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

206.26M

Net Income (TTM)

−550.40M

Op. CF (TTM)

−513.65M

Latest newsMore news →

Yinuo Medical (B) announced its interim results for the six months ended June 2026, with revenue up 38.6% year-on-year and net loss narrowing to RMB 115 million.26d ago

Silverno Pharma announced it has built an internal AI-driven drug discovery closed loop using proprietary wet-lab data, producing novel large and small molecule entities advancing toward preclinical validation.28d ago

Similar companies

Intellia Therapeutics, Inc.NTLA HighTide Therapeutics Inc02511.HK Nanobiotix S.A.NBTX Novavax, Inc.NVAX Absci CorporationABSI Immunocore Holdings plcIMCR Find similar companies →

Latest newsMore news →

Yinuo Medical (B) announced its interim results for the six months ended June 2026, with revenue up 38.6% year-on-year and net loss narrowing to RMB 115 million.26d ago Silverno Pharma announced it has built an internal AI-driven drug discovery closed loop using proprietary wet-lab data, producing novel large and small molecule entities advancing toward preclinical validation.28d ago